Hypothesis

In aging, protein aggregates are not merely garbage but serve as redox‑buffering scaffolds that trap reactive oxygen species (ROS) and redox‑active metals. When autophagy is enhanced (e.g., by disrupting the BCL‑2/Beclin‑1 interaction) these aggregates are dismantled, releasing the sequestered oxidants. If the cell’s antioxidant capacity is not simultaneously upregulated, the sudden increase in bioavailable ROS causes oxidative damage that outweighs the benefit of aggregate removal. Thus, lifespan extension from autophagy activation depends on coupling aggregate clearance with bolstered antioxidant defenses.

Mechanistic Reasoning

1. Aggregate composition – Age‑related insolubility studies show enrichment of cysteine‑rich, metal‑binding proteins (e.g., SOD1, ferritin) within aggregates [PMC3501694]; these proteins can chelate Fe²⁺/Cu⁺ and scavenge ROS.
2. Autophagy‑dependent release – Genetic disruption of BCL‑2/Beclin‑1 increases basal autophagy and reduces aggregate load [PMC5992097]; we predict this process liberates bound metals and ROS into the cytosol.
3. Redox imbalance – Aged brains exhibit ~20 % slower protein turnover and accumulating aggregates [sciadv.abn4437]; simultaneously, antioxidant enzymes (e.g., glutathione peroxidase) decline with age, creating a vulnerable redox environment.
4. Phenotypic outcome – If released oxidants exceed scavenging capacity, lipid peroxidation, DNA damage, and senescence markers rise, potentially offsetting any proteostatic gains.

Testable Predictions

• Prediction 1: In aged mice with Beclin-1^F121A mutation (enhanced autophagy), aggregate levels will decrease, but cytosolic labile iron and H₂O₂ will transiently rise shortly after autophagy induction.
• Prediction 2: Co‑overexpressing a mitochondrial-targeted catalase or iron‑chelator (e.g., ferritin heavy chain) with Beclin-1^F121A will prevent the ROS spike and yield greater lifespan extension than autophagy enhancement alone.
• Prediction 3: Pharmacological autophagy induction (e.g., rapamycin) in aged wild‑type mice will improve clearance only when paired with N‑acetylcysteine supplementation; otherwise, markers of oxidative stress (4‑HNE, γ‑H2AX) will increase.

Experimental Design

Models: 24‑month‑old C57BL/6 mice; groups: (1) control, (2) Beclin-1^F121A, (3) Beclin-1^F121A + mito‑catalase, (4) Beclin-1^F121A + ferritin HC, (5) rapamycin, (6) rapamycin + NAC.

Readouts (at 0, 3, 7, 14 days post‑intervention):

• Filter‑trap assay for insoluble protein aggregates.
• Cytosolic labile iron (Calcein‑AM fluorescence) and H₂O₂ (HyPer sensor).
• Oxidative damage: 4‑HNE adducts, protein carbonyls, γ‑H2AX foci.
• Autophagic flux (LC3‑II/I, p62).
• Lifespan and healthspan metrics (grip strength, rotarod).

Analysis: Compare ROS levels and damage markers across groups; test whether antioxidant co‑intervention abrogates the ROS increase and correlates with superior lifespan extension.

Falsifiability

If aggregate dissolution via autophagy activation does not produce a measurable rise in cytosolic labile iron or ROS, or if antioxidant co‑expression fails to improve longevity beyond autophagy alone, the hypothesis is refuted. Conversely, a consistent ROS surge that is mitigated by antioxidant support, coupled with synergistic lifespan benefits, would support the model.

Broader Implication

This reframes aggregates as transient, protective sinks for redox stress. Therapeutic strategies that solely target aggregate clearance may need to incorporate redox‑balancing adjuncts to avoid exchanging one form of proteotoxic stress for another.